MPA Pharma GmbH
bd_9d89b9eef8859e67 · schema v1 · pii pii-v2
Full breach record for MPA Pharma GmbH →2 incidents on fileThreat-actor claim — not a regulatory filing
This row is a claim by the ransomware group Rhysida on its public extortion blog. It has not been validated by the victim or any regulator. Treat attribution and counts as the threat actor's assertion until a regulatory filing or victim disclosure corroborates them.
Source: Ransomware.live
Post text · scraped from the leak site
MPA Pharma MPA Pharma GmbH is an internationally active, rapidly growing company specializing in the import and trade of high-quality pharmaceuticals, including both patented and generic products. 2,899,290 files, ~5.8 TBPharmaceutical companyCategories: accounting records and database backups, government audits (customs / corporate tax / social security / wage tax),corporate ownership (nominee structure, beneficial-ownership filings, related-party payments), narcotics/BtM records (opioids, cannabis, precursors),litigation files, executive and employee personal data, IT artifacts, pharmacovigilance correspondence.Credit cards with CVV of executives, Oltersdorf ID card valid until 2030, the Pfeiffer letter on the hidden Paranova Pack B.V., UBO passportsSQL backups (17.7 million general-ledger rows), commercial register extract (HRB), organizational chartCredentials (TIER 1) - a list of all password files (values not repeated here, stored in the MPA PASSWORDS report)Government audits - customs 17,011.77 EUR with a breakdown, corporate tax +202,203.18 EUR, social security (DRV) 23,134.96 EUR with a separate case against the managing director, wage-tax auditNarcotics (BtM) - permits (318 04 74), reconciliations of 588 rows / 93 differences, fentanyl, hydromorphone, oxycodone, tapentadol, unexplained remainders of 1-13 units, documentation gap 2017-2020, cannabis up to 22 percent THC, precursorsLitigation - MSD/Merck memo, settlement agreement, Amgros judgment 5,180,043.09 DKK, complaint to the Ministry of Health, arbitration filingPeople, security, pharmacovigilance, bulk financial recordsArtifacts - leadership phone book, employee medical documents, Eli Lilly 2025, AstraZeneca, rebate contracts, a list of all produced reports More
J jump to incidentP pin to compareR raw source
Incident timeline — mostly unverified
? — ?
Breach window unknown
Sep 18, 2026
Claim posted
—
No filing yet · watching
Compliance clocks stay unassessable until a regulatory filing lands. Dashed segments fill in automatically when corroboration arrives.
Claim → filing
—
Compliance clock
Not assessable
Evidence ladder
Attacker assertion only. Establishes: claim date, group, alleged victim.
Unlocks: incident narrative, operational impact. Still no compliance clock.
Unlocks: discovery date, data types, affected count, compliance clock.
Unlocks: materiality, stated response, full audit trail. Ceiling removed.
No regulatory filing corroborates this yet — it is the attacker's own assertion. Watch this entity to be notified the moment a filing corroborates or contradicts it.
Source ceiling
- actor name
- victim claim
- ransom/leak status
- discovery date
- materiality
- notification
- affected count
- confirmed data types
- compliance clock
The ✕ fields stay blank until a regulatory filing or victim disclosure lands.
rhysida
According to ransomware.live, Rhysida is a ransomware-as-a-service (RAAS) group that emerged in May 2023. The group utilizes a namesake ransomware through phishing attacks and Cobalt Strike to breach the targets' networks and deploy their payloads. The group threatens to publicly distribute exfiltrated data if the ransom is not paid, and it's worth mentioning that Rhysida is still in the early stages of development. The ransomware leaves PDF notes in the affected folders, instructing victims to contact the group through its portal, and payment is made via Bitcoin. After encryption, the ransomware appends the extension '.ryshida' to encrypted files. Source: https://github.com/crocodyli/ThreatActors-TTPs